Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Microsatellite Stability Assessment	NCIT_C139286	[An assessment of the variability in length of an individual's microsatellite sequences; microsatellite length instability may be due to mismatch repair protein mutation.]
Used Family or Friend's Tablet	NCIT_C139287	[A response indicating that an individual used a tablet belonging to a friend or family member.]
Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma	NCIT_C139288	[An EBV-positive peripheral T-cell lymphoma that arises from the lymph nodes. It is characterized by a monomorphic pattern of infiltration and abscence of the angiodestruction and necrosis seen in extranodal NK/T-cell lymphomas. These lymphomas are more common in elderly patient, or in the setting of immune deficiency. For the time being, they are considered a variant of peripheral T-cell lymphoma, not otherwise specified. (WHO 2017)]
A260 to A230 Ratio	NCIT_C139281	[An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 230nm respectively.]
Fluorescent Tag Type	NCIT_C139282	[The type of fluorescent label or dye that is used in a fluorescence-based assay.]
Number of Nucleotide Markers Exhibiting Instability	NCIT_C139283	[The total number of nucleotide repeat markers tested that exhibit instability in a biological specimen.]
Percent of Nucleotide Markers Exhibiting Instability	NCIT_C139284	[The relative measurement (percentage) of nucleotide repeat markers exhibiting instability to all nucleotide repeat markers tested in a biological specimen.]
A260 to A280 Ratio	NCIT_C139280	[An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 280nm respectively.]
IPSS Risk Category	NCIT_C139296	[The risk category for myelodysplastic syndrome progression that is derived from IPSS risk score.]
IPSS Risk Score 0	NCIT_C139297	[An International Prognostic Scoring System for Myelodysplastic Syndrome risk score of 0, corresponding to low risk.]
IPSS Risk Score	NCIT_C139295	[The total score for myelodysplastic syndrome progression that considers the percentage of blasts in bone marrow (scored on a scale from zero to 2), chromosome abnormalities (scored from zero to 1), and the patient's blood counts (scored as zero or 0.5).]
IPSS Risk Score 0.5 to 1.0	NCIT_C139298	[An International Prognostic Scoring System for Myelodysplastic Syndrome risk score of 0.5 to 1.0, corresponding to intermediate-1 risk.]
IPSS Risk Score 1.5 to 2.0	NCIT_C139299	[An International Prognostic Scoring System for Myelodysplastic Syndrome risk score of 1.5-2.0, corresponding to intermediate-2 risk.]
TAF12 Gene Product	NCIT_C139292	[A protein encoded by the TAF12 gene.]
Patient Navigation Program	NCIT_C139294	[A healthcare program that is designed to guide a patient through the healthcare system and reduce barriers to timely screening, follow-up, diagnosis, treatment, and supportive care.]
TP63 Gene Rearrangement	NCIT_C139290	[A molecular abnormality indicating rearrangement of the TP63 gene.]
TP63 Gene	NCIT_C91791	[This gene plays a role in both transcriptional regulation and limb development.]
Advanced Head and Neck Squamous Cell Carcinoma	NCIT_C139291	[A head and neck squamous cell carcinoma that has spread extensively to other anatomical sites or is no longer responding to treatment.]
Advanced Head and Neck Carcinoma	NCIT_C129861	[A head and neck carcinoma that has spread extensively to other anatomical sites or is no longer responding to treatment.]
Metastatic Head and Neck Squamous Cell Carcinoma	NCIT_C148153	[A head and neck squamous cell carcinoma which has spread from the original site of growth to another anatomic site.]